The global blood cancer drugs market was valued at about $33 billion in 2018 and is expected to grow to $43.74 billion at a CAGR of 7.3% through 2022. Global Blood Cancer Drugs Market Report 2020 provides strategists, marketers and senior management with the critical information they need to assess the global blood cancer drugs market. The blood cancer drugs market consists of sales of drugs to treat all types of blood cancers. The blood cancer drugs market excludes biologics and includes establishments that produce drugs used in chemotherapy, surgery and radio therapies for treating leukemia, lymphoma, and myeloma.
Scientific Tracks Abstracts: Virology & Mycology
Poster Presentations: Journal of Antivirals & Antiretrovirals